U.S. Supreme Court slaps big pharma for paying generic makers to delay lower cost medications
Ruled 5-3 that agreements between the makers of name-brand and generic drugs to delay the generics' availability can be illegal, an outcome cheered by consumer groups.
LATEST NEW HAMPSHIRE ANGLE
NH health officials discover listeria contamination in ready-made chicken salad, recall ordered
BIA - Jim Roche: Limited provider networks could be the cost-cutting solution we’ve been looking for
Gun Review: Ruger SR1911 Commander (VIDEO)
What's open / what's closed on Thanksgiving